(Q39833293)

15 September 2017

title

Identification of an HLA-A*0201-restrictive CTL epitope from MUC4 for applicable vaccine therapy (English)

1 reference

15 September 2017

Junli Wu

1

1 reference

15 September 2017

Jishu Wei

2

1 reference

15 September 2017

Kai Meng

3

1 reference

15 September 2017

Jianmin Chen

4

1 reference

15 September 2017

Wentao Gao

5

1 reference

15 September 2017

Jingjing Zhang

6

1 reference

15 September 2017

Zekuan Xu

7

1 reference

15 September 2017

Yi Miao

8

1 reference

15 September 2017

publication date

1 January 2009

1 reference

Immunopharmacology and Immunotoxicology

15 September 2017

published in

1 reference

15 September 2017

volume

31

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

468-476

1 reference

Molecular cloning and chromosomal localization of a novel human tracheo-bronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

MUC4 expression is increased in dysplastic cervical disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Therapeutic vaccination for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Identification of a major histocompatibility complex class I-restricted T-cell epitope in the tumour-associated antigen, 5T4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Cloning, chromosomal localization and characterization of the murine mucin gene orthologous to human MUC4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

WT1 peptide vaccine for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

A structure-based approach for prediction of MHC-binding peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Identification of immunodominant regions among promiscuous HLA-DR-restricted CD4+ T-cell epitopes on the tumor antigen MAGE-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Prediction of HLA-A2-restricted CTL epitope specific to HCC by SYFPEITHI combined with polynomial method

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

HLA typing demands for peptide-based anti-cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

Identification of a -Cell-Specific HLA Class I Restricted Epitope in Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08923970902795203

10.1080/08923970902795203

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference